From speeding up drug discovery to enabling sustainable crop protection and crafting sophisticated scents, the science of retrosynthesis is being revolutionised by digital tools.
Now, the advent of advanced platforms like SYNTHIA is bringing algorithmic power to bear on this challenge.
By starting from widely available building blocks, retrosynthetic software can sometimes design 1-, 2-, or 3-step syntheses, significantly reducing resource consumption and timelines.
Angelo Lanzilotto , a chemist with a rich background spanning antibody discovery at Amgen Canada and small molecule drug optimization at Selvita , now contributes to Merck KGaA ’s digital chemistry division.
According to Chemistry World, Lanzilotto and his team are actively developing and commercializing software solutions tailored to the needs of chemical industries.
From speeding up drug discovery to enabling sustainable crop protection and crafting sophisticated scents, the science of retrosynthesis is being revolutionised by digital tools. As the demand for faster and more efficient synthesis of complex molecules intensifies, industries ranging from pharmaceuticals to agrochemicals and flavours are embracing next-generation software to stay ahead.Retrosynthesis, the art and science of planning how to assemble a target molecule from simpler starting materials, has traditionally relied on the deep expertise of chemists. Now, the advent of advanced platforms like SYNTHIA is bringing algorithmic power to bear on this challenge. Unlike earlier systems that often made predictions based solely on statistical models, SYNTHIA leverages a vast library of expert-coded reaction rules and scalable algorithms, effectively acting as a digital chemist that can suggest practical, industry-ready synthetic pathways.In a forthcoming large-scale evaluation, SYNTHIA’s capabilities are being benchmarked across three of the most innovation-intensive chemical industries: pharmaceuticals, agrochemicals, and flavours & fragrances. Using comprehensive datasets representative of each sector—ranging from drug candidates and crop-protection agents to fragrance compounds—the software is tasked with identifying viable synthetic routes using a library of 14 million commercially available chemicals. This exercise draws on more than 120,000 expert-curated reaction steps, pushing the boundaries of what algorithmic retrosynthesis can achieve in real-world settings.According to information shared by Chemistry World , this assessment will delve into SYNTHIA’s performance across these varied chemical spaces, analyzing not only its success rates but the unique challenges each industry presents. For instance, the complexity of pharmaceutical molecules, the scalability requirements of agrochemicals, and the nuanced sensory characteristics of fragrance compounds all test the flexibility and intelligence of retrosynthetic algorithms.One of the major insights emerging from such evaluations is the impact of molecular complexity on the software’s ability to deliver practical synthetic routes. Molecules with multiple chiral centers, for example, present significant challenges due to the precise control required over stereochemistry. The concept of synthetic accessibility—essentially, how difficult it is to make a molecule from commercially available building blocks—also plays a crucial role. Metrics such as the synthetic accessibility score are being closely examined to determine how they correlate with the likelihood of SYNTHIA finding a feasible pathway.Shorter synthetic routes are particularly valued in industry, both for cost efficiency and sustainability. By starting from widely available building blocks, retrosynthetic software can sometimes design 1-, 2-, or 3-step syntheses, significantly reducing resource consumption and timelines. This approach is not only transformative for pharmaceutical companies seeking to accelerate drug development but also for manufacturers of agrochemicals and perfumes, where speed-to-market is a competitive advantage. Angelo Lanzilotto , a chemist with a rich background spanning antibody discovery at Amgen Canada and small molecule drug optimization at Selvita , now contributes to Merck KGaA ’s digital chemistry division. According to Chemistry World, Lanzilotto and his team are actively developing and commercializing software solutions tailored to the needs of chemical industries. Their work positions retrosynthetic tools not just as aids but as integral components of the modern chemist’s toolkit.Reflecting on the shift, industry observers note that digital retrosynthesis is enabling chemists to think more creatively and strategically, freeing them from the tedium of manual pathway design and allowing greater focus on innovation and problem-solving.For Indian chemical manufacturers and research institutes, the adoption of such platforms holds particular promise. With the government’s push toward self-reliance in pharmaceuticals and agrochemicals, and the growing global market for natural and synthetic fragrances, automated retrosynthesis could become a cornerstone of India’s innovation strategy. Moreover, the ability to rationalize synthetic choices using accessibility metrics and digital simulations supports both green chemistry initiatives and regulatory compliance.Collaborations between global leaders like Merck and local players could further accelerate the diffusion of these technologies, driving productivity gains and fostering new business models in chemical R&D.As chemistry moves deeper into the digital era, retrosynthetic software stands poised to transform not only how molecules are made but how entire industries approach innovation. While challenges remain—particularly in handling highly complex or novel molecular architectures—the trajectory is clear: digital retrosynthesis is set to become an indispensable enabler for the next generation of pharmaceutical, agrochemical, and fragrance breakthroughs.For industry leaders and research institutions alike, now is the moment to invest in the digital infrastructure and skills that will define the future of synthesis planning and chemical innovation.
